<DOC>
	<DOCNO>NCT00434733</DOCNO>
	<brief_summary>This study design evaluate immunogenicity , safety tolerability 2 dose FLUAD-H5N1 vaccine compare 2 dos trivalent , interpandemic FLUAD , administer 3 week apart .</brief_summary>
	<brief_title>Immunogenicity , Safety Tolerability Two Doses FLUAD-H5N1 Influenza Vaccine Adult Elderly Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Subjects 18 year age sign informed consent Receipt another investigational agent within 4 week Receipt influenza vaccination current season 2006/2007 . acute disease infection , history neurological symptom sign , know suspected impairment immune function , serious disease , bleed diathesis fever ( defined axillary temperature ³38.0°C ) within 3 day ( prior Visit 1 ) Pregnant breastfeed female childbearing potential refuse use acceptable method birth control Surgery plan study period Hypersensitivity egg , chicken protein , chicken feather , influenza viral protein , neomycin polymyxin component study vaccine Receipt another vaccine within 3 week prior Visit 1 plan vaccination within 3 week follow last study vaccination History ( current ) drug alcohol abuse Any condition , , opinion Investigator , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Influenza H5N1 , pandemic</keyword>
</DOC>